Kerrisdale Advisers’s Labcorp LH Stock Holding History

Kerrisdale Advisers’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,369	Closed	-$889K	–	99
2024 Q2	$889K	Hold	4,369	–	–	0.28%	60
2024 Q1	$954K	Hold	4,369	–	–	0.3%	59
2023 Q4	$993K	Sell	4,369 -725	-14%	-$152K	0.3%	55
2023 Q3	$1.02M	Sell	5,094 -9,799	-66%	-$2.07M	0.32%	58
2023 Q2	$3.09M	Hold	14,893	–	–	0.83%	40
2023 Q1	$2.94M	Hold	14,893	–	–	0.87%	36
2022 Q4	$3.01M	Hold	14,893	–	–	0.89%	33
2022 Q3	$2.62M	Hold	14,893	–	–	0.64%	35
2022 Q2	$3M	Buy	+14,893	New	+$3.17M	0.94%	35
2021 Q1	–	Sell	-11,598	Closed	-$2.03M	–	70
2020 Q4	$2.03M	Sell	11,598 -82,863	-88%	-$14.3M	0.16%	55
2020 Q3	$15.3M	Buy	+94,461	New	+$15M	1.15%	33

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kerrisdale Advisers's LH Position: Q3 2024 in Review

Kerrisdale Advisers sold out of Labcorp (LH) in Q3 2024, closing a stake of 4,369 shares — an estimated $889K sold.

Kerrisdale Advisers first reported a position in LH in Q3 2020 and held it in 11 quarters. The position peaked at $15.3M in Q3 2020. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.

Kerrisdale Advisers reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
Kerrisdale Advisers sold 4,369 Labcorp shares in Q3 2024, an estimated $889K.
Kerrisdale Advisers first reported a position in Labcorp in Q3 2020 and held it in 11 quarters.
Kerrisdale Advisers's Labcorp position peaked at $15.3M in Q3 2020.
920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Kerrisdale Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.